|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
1.65/2.38
|
企業價值
35.53B
|
資產負債 |
每股賬面淨值
5.07
|
現金流量 |
現金流量率
0.02
|
損益表 |
收益
3.62B
|
每股收益
8.71
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2025/01/21 18:45 EST
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. |